logo
Plus   Neg
Share
Email

Vertex Pharma: FDA Approves Expanded Indication For KALYDECO - Quick Facts

Vertex Pharmaceuticals Inc. (VRTX) announced the U.S. FDA has approved an expanded indication for KALYDECO, which allows physicians to treat the underlying cause of cystic fibrosis in eligible infants as young as six months of age for the first time, with the potential to modify the course of the disease. The FDA approval is based on data from a 24-week Phase 3 open-label safety cohort.

KALYDECO is currently approved in the U.S., Canada and EU for the treatment of cystic fibrosis in patients ages 12 months and older.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Target Corp. (TGT) announced a retail collaboration with Walt Disney Co. (DIS) that will open 25 Disney stores within select Target stores nationwide on October 4, with 40 additional locations opening by October 2020. Target will also open a store at Flamingo Crossings Town Center at the western entrance of the Walt Disney World Resort in 2021. Whole Foods Market stores have recalled Decorated Red Apple Cookies as they may contain undeclared egg. People who have an allergy or severe sensitivity to these allergens run the risk of serious or life-threatening allergic reaction if they consume these products. The cookies were sold by the... Norwex has announced voluntary recall of about 58,000 rubber brooms due to laceration hazard. According to the company, handles of the recalled brooms can break in half, exposing a metal inner rim, posing a laceration hazard to the user. The recall involves extendable indoor/outdoor white rubber...
Follow RTT